SLC5A2 and type 2 diabetes mellitus: Materials and Methods: This ambispective (retrospective and prospective) observational study enrolled adults with type 2 diabetes who had received first-line metformin therapy, or an alternative antidiabetic agent in cases of intolerance or contraindication, excluding SGLT2 inhibitors, for a minimum of 12 months prior to recruitment.